Back to top

AC Immune announces interim data from first three cohorts of ABATE trial

AC Immune (ACIU) announced interim data from the first three cohorts of 74 patients with prodromal Alzheimer’s disease in the Phase 1b/2 ABATE tria...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AC Immune (ACIU)